Formulation and delivery strategies of ibuprofen: challenges and opportunities

References

• Dionne RA, McCullagh L. Enhanced analgesia and suppression of plasma beta-endorphin by the S(+)-isomer of ibuprofen. Clin Pharmacol Ther. 1998;63:694–701.
   PubMed Web of Science ®Google Scholar
• Bolten D, Lietzow R, Tuerk M. Solubility of ibuprofen, phytosterol, salicylic acid, and naproxen in aqueous solutions. Chem Eng Technol. 2013;36:426–434.
   Web of Science ®Google Scholar
• Rashid A, White ET, Howes T, et al. Effect of solvent composition and temperature on the solubility of ibuprofen in aqueous ethanol. J Chem Eng Data. 2014;59:2699–2703.
   Web of Science ®Google Scholar
• Klueglich M, Ring A, Scheuerer S, et al. Ibuprofen extrudate, a novel, rapidly dissolving ibuprofen formulation: relative bioavailability compared to ibuprofen lysinate and regular ibuprofen, and food effect on all formulations. J Clin Pharmacol. 2005;45:1055–1061.
   PubMed Web of Science ®Google Scholar
• Manrique J, Martinez F. Solubility of ibuprofen in some ethanol + water cosolvent mixtures at several temperatures. Lat Am J Pharm. 2007;26:344–354.
   Web of Science ®Google Scholar
• Dawood MY, Khan-Dawood FS. Clinical efficacy and differential inhibition of menstrual fluid prostaglandin F 2α in a randomized, double-blind, crossover treatment with placebo, acetaminophen, and ibuprofen in primary dysmenorrhea. Am J Obstet Gynecol. 2007;196: 35, 1–35.
   PubMed Web of Science ®Google Scholar
• Derry CJ, Derry S, Moore RA, et al. Single dose oral ibuprofen for acute postoperative pain in adults. Cochrane Database Syst Rev. 2009;8:1–127.
   Google Scholar
• Silver S, Gano D, Gerretsen P. Acute treatment of paediatric migraine: a meta-analysis of efficacy. J Paediatr Child Health. 2008;44:3–9.
   PubMed Web of Science ®Google Scholar
• Rainsford K. Ibuprofen: pharmacology, efficacy and safety. Inflammopharmacology. 2009;17:275–342.
   PubMedGoogle Scholar
• Kokki H, Kumpulainen E, Lehtonen M, et al. Cerebrospinal fluid distribution of ibuprofen after intravenous administration in children. Pediatrics. 2007;120:1002–1008.
   PubMed Web of Science ®Google Scholar
• Vyas FI, Rana DA, Patel PM, et al. Randomized comparative trial of efficacy of paracetamol, ibuprofen and paracetamol–ibuprofen combination for treatment of febrile children. Perspect Clin Res. 2014;5:25.
   PubMedGoogle Scholar
• Konstan MW, Byard PJ, Hoppel CL, et al. Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med. 1995;332:848–854.
   PubMed Web of Science ®Google Scholar
• Levis KA, Lane ME, Corrigan OI. Effect of buffer media composition on the solubility and effective permeability coefficient of ibuprofen. Int J Pharm. 2003;253:49–59.
   PubMed Web of Science ®Google Scholar
• Desjardins P, Black P, Papageorge M, et al. Ibuprofen arginate provides effective relief from postoperative dental pain with a more rapid onset of action than ibuprofen. Eur J Clin Pharmacol. 2002;58:387–394.
   PubMed Web of Science ®Google Scholar
• Mehlisch DR, Sykes J. Ibuprofen blood plasma levels and onset of analgesia. Int J Clin Pract. 2013;67(Suppl. 178):3–8.
   Web of Science ®Google Scholar
• Wood DM, Monaghan J, Streete P, et al. Fatality after deliberate ingestion of sustained-release ibuprofen: a case report. England: United Kingdom: Guy's and St Thomas' Poisons Unit, Guy's and St Thomas' NHS Foundation Trust, London, UK; 2006. p. R44.
   Google Scholar
• Davies NM. Clinical pharmacokinetics of ibuprofen. The first 30 years. Clin Pharmacokinet. 1998;34:101–154.
   PubMed Web of Science ®Google Scholar
• Legg TJ, Laurent AL, Leyva R, et al. Ibuprofen sodium is absorbed faster than standard ibuprofen tablets: results of two open-label, randomized, crossover pharmacokinetic studies. Drugs R D. 2014;14:283–290.
   PubMedGoogle Scholar
• Abioye AO, Kola-Mustapha A, Ruparelia K. Impact of in situ granulation and temperature quenching on crystal habit and micromeritic properties of ibuprofen-cationic dextran conjugate crystanules. Int J Pharm. 2014;462:83–102.
   PubMed Web of Science ®Google Scholar
• Nokhodchi A, Amire O, Jelvehgari M. Physico-mechanical and dissolution behaviours of ibuprofen crystals crystallized in the presence of various additives. Daru: J Faculty Pharm (Tehran University of Medical Sciences). 2010;18:74.
   PubMed Web of Science ®Google Scholar
• Tan A, Eskandar NG, Rao S, et al. First in man bioavailability and tolerability studies of a silica–lipid hybrid (Lipoceramic) formulation: a Phase I study with ibuprofen. Drug Deliv Transl Res. 2014;4:212–221.
   PubMed Web of Science ®Google Scholar
• Potthast H, Dressman J, Junginger H, et al. Biowaiver monographs for immediate release solid oral dosage forms: ibuprofen. J Pharm Sci. 2005;94:2121–2131.
   PubMed Web of Science ®Google Scholar
• Han X, Ghoroi C, Dave R. Dry coating of micronized API powders for improved dissolution of directly compacted tablets with high drug loading. Int J Pharm (Amsterdam, Neth.). 2013;442:74–85.
   PubMed Web of Science ®Google Scholar
• Newa M, Bhandari Krishna H, Li Dong X, et al. Preparation and evaluation of immediate release ibuprofen solid dispersions using polyethylene glycol 4000. Biol Pharm Bull. 2008;31:939–945.
   PubMed Web of Science ®Google Scholar
• Kang Myung J, Jung Soo Y, Song Woo H, et al. Immediate release of ibuprofen from Fujicalin®-based fast-dissolving self-emulsifying tablets. Drug Dev Ind Pharm. 2011;37:1298–1305.
   PubMed Web of Science ®Google Scholar
• Oberoi LM, Alexander KS, Riga AT. Solubility Enhancement of Ibuprofen Using Nicotinamide as a Hydrotropic Agent – Study of Interaction by Thermal, Spectroscopic and Microscopic Techniques. Abstracts, 36th Central Regional Meeting of the American Chemical Society, Indianapolis, IN, United States, 2–4 June 2004:GEN-272.
   Google Scholar
• Dugar RP, Gajera BY, Dave RH. Fusion method for solubility and dissolution rate enhancement of ibuprofen using block copolymer poloxamer 407. AAPS PharmSciTech. 2016;17:1428–1440.
   PubMed Web of Science ®Google Scholar
• Milhem OM, Myles C, McKeown NB, et al. Polyamidoamine Starburst dendrimers as solubility enhancers. Int J Pharm. 2000;197:239–241.
   PubMed Web of Science ®Google Scholar
• Moore RA, Derry S, Straube S, et al. Faster, higher, stronger? Evidence for formulation and efficacy for ibuprofen in acute pain. PAIN®. 2014;155:14–21.
   PubMed Web of Science ®Google Scholar
• Gandhi P, Patil S, Aher S, et al. Ultrasound-assisted preparation of novel ibuprofen-loaded excipient with improved compression and dissolution properties. Drug Dev Ind Pharm. 2016;42:1553–1563.
   PubMed Web of Science ®Google Scholar
• Mauludin R, Moeschwitzer J, Mueller RH. Fast dissolving ibuprofen nanocrystal-loaded solid dosage forms. Int J Pharm Pharm Sci. 2012;4:543–549.
   Google Scholar
• Soares FL, Carneiro RL. Green synthesis of ibuprofen–nicotinamide cocrystals and in-line evaluation by Raman spectroscopy. Cryst Growth Des. 2013;13:1510–1517.
   Web of Science ®Google Scholar
• Nikolakakis I, Kachrimanis K, Malamataris S. Relations between crystallisation conditions and micromeritic properties of ibuprofen. Int J Pharm. 2000;201:79–88.
   PubMed Web of Science ®Google Scholar
• Garekani H, Sadeghi F, Badiee A, et al. Crystal habit modifications of ibuprofen and their physicomechanical characteristics. Drug Dev Ind Pharm. 2001;27:803–809.
   PubMed Web of Science ®Google Scholar
• Montes A, Gordillo MD, Pereyra C, et al. Ibuprofen-polymer precipitation using supercritical CO2 at low temperature. J Supercrit Fluids. 2014;94:91–101.
   Web of Science ®Google Scholar
• Sinha B, Mueller RH, Moeschwitzer JP. Systematic investigation of the cavi-precipitation process for the production of ibuprofen nanocrystals. Int J Pharm (Amsterdam, Neth.). 2013;458:315–323.
   PubMed Web of Science ®Google Scholar
• Khan S, Matas M, Zhang J, et al. Nanocrystal preparation: low-energy precipitation method revisited. Cryst Growth Des. 2013;13:2766–2777.
   Web of Science ®Google Scholar
• Kocbek P, Baumgartner S, Kristl J. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs. Int J Pharm. 2006;312:179–186.
   PubMed Web of Science ®Google Scholar
• Ragab DM, Rohani S. Particle engineering strategies via crystallization for pulmonary drug delivery. Org Process Res Dev. 2009;13:1215–1223.
   Web of Science ®Google Scholar
• Abdel-Rahman SI, Mahrous GM, El-Badry M. Preparation and comparative evaluation of sustained release metoclopramide hydrochloride matrix tablets. Saudi Pharm J. 2009;17:283–288.
   PubMedGoogle Scholar
• Swain RP, Kumari TR, Panda S. Formulation development and evaluation of sustained release ibuprofen tablets with acrylic polymers (Eudragit) and HPMC. Int J Pharm Pharm Sci. 2016;5:8.
   Google Scholar
• Giri TK, Kumar K, Alexander A, et al. A novel and alternative approach to controlled release drug delivery system based on solid dispersion technique. Bull Faculty Pharmacy (Cairo University). 2012;50:147–159.
   Google Scholar
• Essa S, Rabanel JM, Hildgen P. Effect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly (D, L-lactide)(PLA) based nanoparticles. Eur J Pharm Biopharm. 2010;75:96–106.
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev. 2001;53:283–318.
   PubMed Web of Science ®Google Scholar
• Shang Q, Huang S, Zhang A, et al. The binary complex of poly(PEGMA-co-MAA) hydrogel and PLGA nanoparticles as a novel oral drug delivery system for ibuprofen delivery. J Biomater Sci, Polym Ed. 2017;28:1874–1887.
   PubMed Web of Science ®Google Scholar
• Jiang B, Hu L, Gao C, et al. Ibuprofen-loaded nanoparticles prepared by a co-precipitation method and their release properties. Int J Pharm. 2005;304:220–230.
   PubMed Web of Science ®Google Scholar
• Islam N, Ferro V. Recent advances in chitosan-based nanoparticulate pulmonary drug delivery. Nanoscale. 2016;8:14341–14358.
   PubMed Web of Science ®Google Scholar
• Abioye AO, Armitage R, Kola-Mustapha AT. Thermodynamic changes induced by intermolecular interaction between ibuprofen and chitosan: effect on crystal habit, solubility and in vitro release kinetics of ibuprofen. Pharm Res. 2016;33:337–357.
   PubMed Web of Science ®Google Scholar
• Ofokansi KC, Kenechukwu FC. Formulation development and evaluation of drug release kinetics from colon-targeted ibuprofen tablets based on Eudragit RL 100-chitosan interpolyelectrolyte complexes. ISRN Pharmaceutics. 2013;2013.
   PubMedGoogle Scholar
• Huynh NT, Passirani C, Saulnier P, et al. Lipid nanocapsules: a new platform for nanomedicine. Int J Pharm. 2009;379:201–209.
   PubMed Web of Science ®Google Scholar
• Liang H. Medicinal composition containing ibuprofen liposome, chondroitin sulfate and curcumin for treating osteoarthritis, and preparation method thereof. Application: CN patent 2016-10221218, 105878268. 2016 20160407.
   Google Scholar
• Chen F, Zhu Y. Chitosan enclosed mesoporous silica nanoparticles as drug nano-carriers: sensitive response to the narrow pH range. Microporous Mesoporous Mater. 2012;150:83–89.
   Web of Science ®Google Scholar
• Yang Y-J, Tao X, Hou Q, et al. Fluorescent mesoporous silica nanotubes incorporating CdS quantum dots for controlled release of ibuprofen. Acta Biomater. 2009;5:3488–3496.
   PubMed Web of Science ®Google Scholar
• Li Z, Barnes JC, Bosoy A, et al. Mesoporous silica nanoparticles in biomedical applications. Chem Soc Rev. 2012;41:2590–2605.
   PubMed Web of Science ®Google Scholar
• Saino V, Monti D, Burgalassi S, et al. Optimization of skin permeation and distribution of ibuprofen by using nanostructures (coagels) based on alkyl vitamin C derivatives. Eur J Pharm Biopharm. 2010;76:443–449.
   PubMed Web of Science ®Google Scholar
• Brown MB, Martin GP, Jones SA, et al. Dermal and transdermal drug delivery systems: current and future prospects. Drug Deliv. 2006;13:175–187.
   PubMed Web of Science ®Google Scholar
• Coderch L, López O, de la Maza A, et al. Ceramides and skin function. Am J Clin Dermatol. 2003;4:107–129.
   PubMed Web of Science ®Google Scholar
• Patel A, Bell M, O’Connor C, et al. Delivery of ibuprofen to the skin. Int J Pharm. 2013;457:9–13.
   PubMed Web of Science ®Google Scholar
• Giese U. Absorption and distribution of ibuprofen from a cream formulation after dermal administration to guinea pigs. Arzneimittelforschung. 1990;40:84–88.
   PubMed Web of Science ®Google Scholar
• Steen AE, Reeh PW, Geisslinger G, et al. Plasma levels after peroral and topical ibuprofen and effects upon low pH‐induced cutaneous and muscle pain. Eur J Pain. 2000;4:195–209.
   PubMed Web of Science ®Google Scholar
• Berner G, Engels B, Vögtle-Junkert U. Percutaneous ibuprofen therapy with Trauma–Dolgit gel: bioequivalence studies. Drugs Exp Clin Res. 1988;15:559–564.
   Google Scholar
• Tegeder I, Muth‐Selbach U, Lötsch J, et al. Application of microdialysis for the determination of muscle and subcutaneous tissue concentrations after oral and topical ibuprofen administration. Clin Pharmacol Ther. 1999;65:357–368.
   PubMed Web of Science ®Google Scholar
• Djekic L. Ibuprofen delivery: pharmaceutical nanotechnology approach. Ibuprofen. 2013;167:311–348.
   Google Scholar
• Gaur PK, Bajpai M, Mishra S, et al. Development of ibuprofen nanoliposome for transdermal delivery: physical characterization, in vitro/in vivo studies, and anti-inflammatory activity. Artif Cells Nanomed Biotechnol. 2016;44:370–375.
   PubMed Web of Science ®Google Scholar
• Abdel-Mottaleb MM, Neumann D, Lamprecht A. Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers. Eur J Pharm Biopharm. 2011;79:36–42.
   PubMed Web of Science ®Google Scholar
• Irfan M, Verma S, Ram A. Preparation and characterization of Ibuprofen loaded Transferosome as a novel carrier for transdermal drug delivery system. Asian J Pharm Clin Res. 2012;5:162–165.
   Google Scholar
• Benson HA. Transfersomes for transdermal drug delivery. Expert Opin Drug Deliv. 2006;3:727–737.
   PubMed Web of Science ®Google Scholar
• Marianecci C, Rinaldi F, Esposito S, et al. Niosomes encapsulating ibuprofen-cyclodextrin complexes: preparation and characterization. Cdt. 2013;14:1070–1078.
   Google Scholar
• Ghanbarzadeh S, Khorrami A, Arami S. Nonionic surfactant-based vesicular system for transdermal drug delivery. Drug Deliv. 2015;22:1071–1077.
   PubMed Web of Science ®Google Scholar
• Rinaldi F, Del Favero E, Rondelli V, et al. pH-sensitive niosomes: effects on cytotoxicity and on inflammation and pain in murine models. J Enzyme Inhib Med Chem. 2017;32:538–546.
   PubMed Web of Science ®Google Scholar
• Shumilov M, Bercovich R, Duchi S, et al. Ibuprofen transdermal ethosomal gel: characterization and efficiency in animal models. J Biomed Nanotechnol. 2010;6:569–576.
   PubMed Web of Science ®Google Scholar
• Yuan H-l, Yang X, Zhang S-j, et al. Study on formulation screening and in vitro drug release of ibuprofen binary ethosome thermosensitive gel. Zhongguo Yaofang. 2015;26:1389–1392.
   Google Scholar
• Yuan H-l, Hu J-m, Wei Y-h, et al. Preparation of ibuprofen ethosomes and their in vitro transdermal penetration. Zhongguo Xinyao Zazhi. 2013;22:351–354.
   Google Scholar
• Martin W, Koselowske G, Töberich H, et al. Pharmacokinetics and absolute bioavailability of ibuprofen after oral administration of ibuprofen lysine in man. Biopharm Drug Dispos. 1990;11:265–278.
   PubMed Web of Science ®Google Scholar
• Pavliv L, Voss B, Rock A. Pharmacokinetics, safety, and tolerability of a rapid infusion of iv ibuprofen in healthy adults. Am J Health Syst Pharm. 2011;68:47–51.
   PubMed Web of Science ®Google Scholar
• Smith HS, Voss B. Pharmacokinetics of intravenous ibuprofen: implications of time of infusion in the treatment of pain and fever. Drugs. 2012;72:327–337.
   PubMed Web of Science ®Google Scholar
• Müller RH, Peters K. Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction technique. Int J Pharm. 1998;160:229–237.
   Web of Science ®Google Scholar
• Catarina PR, João PF, Sara C, et al. Ibuprofen nanoparticles for oral delivery: proof of concept. J Nanomed Biother Discov. 2013;4:1–5.
   Google Scholar
• Narayanan D, MGG, H L, et al. Poly-(ethylene glycol) modified gelatin nanoparticles for sustained delivery of the anti-inflammatory drug Ibuprofen–Sodium: an in vitro and in vivo analysis. Nanomedicine. 2013;9:818–828.
   PubMed Web of Science ®Google Scholar
• Onischuk AA, Tolstikova TG, Sorokina IV, et al. Analgesic effect from Ibuprofen nanoparticles inhaled by male mice. J Aerosol Med Pulm Drug Deliv. 2009;22:245–253.
   PubMed Web of Science ®Google Scholar
• Onischuk A, Tolstikova T, An’kov S, et al. Ibuprofen, indomethacin and diclofenac sodium nanoaerosol: generation, inhalation delivery and biological effects in mice and rats. J Aerosol Sci. 2016;100:164–177.
   Web of Science ®Google Scholar
• Islam N, Gladki E. Dry powder inhalers (DPIs) – a review of device reliability and innovation. Int J Pharm. 2008;360:1–11.
   PubMed Web of Science ®Google Scholar
• Möschwitzer JP. Drug nanocrystals in the commercial pharmaceutical development process. Int J Pharm. 2013;453:142–156.
   PubMed Web of Science ®Google Scholar
• Rasenack N, Steckel H, Müller BW. Preparation of microcrystals by in situ micronization. Powder Technol. 2004;143:291–296.
   Web of Science ®Google Scholar
• Restani RB, Silva AS, Pires RF, et al. Nano-in-Micro POxylated Polyurea Dendrimers and chitosan dry powder formulations for pulmonary delivery. Part Part Syst Charact. 2016;33:851–858.
   Web of Science ®Google Scholar
• Nesamony J, Shah IS, Kalra A, et al. Nebulized oil-in-water nanoemulsion mists for pulmonary delivery: development, physico-chemical characterization and in vitro evaluation. Drug Dev Ind Pharm. 2014;40:1253–1263.
   PubMed Web of Science ®Google Scholar
• Yazdi AK, Smyth HD. Carrier-free high-dose dry powder inhaler formulation of ibuprofen: physicochemical characterization and in vitro aerodynamic performance. Int J Pharm. 2016;511:403–414.
   PubMed Web of Science ®Google Scholar
• Lestari ML, Müller RH, Möschwitzer JP. Systematic screening of different surface modifiers for the production of physically stable nanosuspensions. J Pharm Sci. 2015;104:1128–1140.
   Web of Science ®Google Scholar
• Pomázi A, Buttini F, Ambrus R, et al. Effect of polymers for aerolization properties of mannitol-based microcomposites containing meloxicam. Eur Polym J. 2013;49:2518–2527.
   Web of Science ®Google Scholar
• Malamatari M, Somavarapu S, Bloxham M, et al. Nanoparticle agglomerates of indomethacin: the role of poloxamers and matrix former on their dissolution and aerosolisation efficiency. Int J Pharm. 2015;495:516–526.
   PubMed Web of Science ®Google Scholar
• Malamatari M, Somavarapu S, Kachrimanis K, et al. Preparation of respirable nanoparticle agglomerates of the low melting and ductile drug ibuprofen: impact of formulation parameters. Powder Technol. 2017;308:123–134.
   Web of Science ®Google Scholar
• Chow AH, Tong HH, Chattopadhyay P, et al. Particle engineering for pulmonary drug delivery. Pharm Res. 2007;24:411–437.
   PubMed Web of Science ®Google Scholar
• Chaubal MV, Popescu C. Conversion of nanosuspensions into dry powders by spray drying: a case study. Pharm Res. 2008;25:2302–2308.
   PubMed Web of Science ®Google Scholar
• Maas SG, Schaldach G, Littringer EM, et al. The impact of spray drying outlet temperature on the particle morphology of mannitol. Powder Technol. 2011;213:27–35.
   Web of Science ®Google Scholar
• Islam N, Tuli RA, George GA, et al. Colloidal drug probe: method development and validation for adhesion force measurement using Atomic Force Microscopy. Adv Powder Technol. 2014;25:1240–1248.
   Web of Science ®Google Scholar
• Muhsin MDA, George G, Beagley K, et al. Effects of chemical conjugation of L-Leucine to chitosan on dispersibility and controlled release of drug from a nanoparticulate dry powder inhaler formulation. Mol Pharm. 2016;13:1455–1466.
   PubMed Web of Science ®Google Scholar
• Sou T, Orlando L, McIntosh MP, et al. Investigating the interactions of amino acid components on a mannitol-based spray-dried powder formulation for pulmonary delivery: a design of experiment approach. Int J Pharm. 2011;421:220–229.
   PubMed Web of Science ®Google Scholar
• Seville PC, Learoyd TP, Li H-Y, et al. Amino acid-modified spray-dried powders with enhanced aerosolisation properties for pulmonary drug delivery. Powder Technol. 2007;178:40–50.
   Web of Science ®Google Scholar
• Sou T, Kaminskas LM, Nguyen T-H, et al. The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules. Eur J Pharm Biopharm. 2013;83:234–243.
   PubMed Web of Science ®Google Scholar
• Verma S, Gokhale R, Burgess DJ. A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions. Int J Pharm. 2009;380:216–222.
   PubMed Web of Science ®Google Scholar
• Van Eerdenbrugh B, Vermant J, Martens JA, et al. A screening study of surface stabilization during the production of drug nanocrystals. J Pharm Sci. 2009;98:2091–2103.
   PubMed Web of Science ®Google Scholar
• Rabbani NR, Seville PC. The influence of formulation components on the aerosolisation properties of spray-dried powders. J Control Release. 2005;110:130–140.
   PubMed Web of Science ®Google Scholar
• Raula J, Thielmann F, Naderi M, et al. Investigations on particle surface characteristics vs. dispersion behaviour of l-leucine coated carrier-free inhalable powders. Int J Pharm. 2010;385:79–85.
   PubMed Web of Science ®Google Scholar
• Edwards DA, Hanes J, Caponetti G, et al. Large porous particles for pulmonary drug delivery. Science. 1997;276:1868–1872.
   PubMed Web of Science ®Google Scholar
• Li X, Vogt FG, Hayes Jr D, et al. Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers. J Aerosol Med Pulm Drug Deliv. 2014;27:81–93.
   PubMed Web of Science ®Google Scholar
• Geller DE, Weers J, Heuerding S. Development of an inhaled dry-powder formulation of tobramycin using PulmoSphere™ technology. J Aerosol Med Pulm Drug Deliv. 2011;24:175–182.
   PubMed Web of Science ®Google Scholar
• Smyth HD. Propellant-driven metered-dose inhalers for pulmonary drug delivery. Expert Opin Drug Deliv. 2005;2:53–74.
   PubMedGoogle Scholar
• Al-Talla Z, Akrawi SH, Tolley LT, et al. Bioequivalence assessment of two formulations of ibuprofen. Drug Des Dev Ther. 2011;5:427–433.
   PubMed Web of Science ®Google Scholar
• Ferrero-Cafiero JM, Gich I, Puntes M, et al. Ibuprofen lysinate, quicker and less variable: relative bioavailability compared to ibuprofen base in a pediatric suspension dosage form. Cp. 2015;53:972–979.
   Google Scholar
• Sörgel F, Fuhr U, Minic M, et al. Pharmacokinetics of ibuprofen sodium dihydrate and gastrointestinal tolerability of short-term treatment with a novel, rapidly absorbed formulation. Cp. 2005;43:3.
   Google Scholar
• Atkinson HC, Stanescu I, Frampton C, et al. Pharmacokinetics and bioavailability of a fixed-dose combination of ibuprofen and paracetamol after intravenous and oral administration. Clin Drug Investig. 2015;35:625–632.
   PubMed Web of Science ®Google Scholar
• Onischuk AA, Tolstikova TG, Sorokina IV, et al. Analgesic effect from ibuprofen nanoparticles inhaled by male mice. J Aerosol Med Pulm Drug Deliv. 2009;22:245–253.
   PubMed Web of Science ®Google Scholar
• Montes A, Litwinowicz AA, Gradl U, et al. Exploring high operating conditions in the ibuprofen precipitation by rapid expansion of supercritical solutions process. Ind Eng Chem Res. 2014;53:474–480.
   Web of Science ®Google Scholar